Prior to joining MDS, he was with OrthoLogic, Inc., a biotech company where he served as President and CEO, developing and implementing a three-year strategic plan that included acquisitions and a collaborative agreement with Quintiles. Prior to that, he was Executive Vice President for Neurology at Serono, Inc., where he was accountable for late stage drug development, including co-development projects with Pfizer. In addition, he has held the positions of Vice President of Marketing and Vice President and Therapeutic Area Leader for CNS, Pain and Infection at Astra-Zeneca USA. He started his industry career at SmithKlineBeecham as International Marketing Manager for two hospital antibiotics and later became Vice President and General Manager of that company’s global Clinical Trials Center. He made the move to the industry side after a medical career that included service on the staffs of four London hospitals as well as the position of International Medical Advisor in SE Asia, where he managed anti-viral drug development trials for The Wellcome Foundation, Ltd.
Educated at London University, James holds Bachelor of Medicine and Bachelor of Surgery degrees from its Royal Free Hospital School of Medicine, and an MBA from its London Business School.
